JOURNAL OF CLINICAL AND BIOMEDICAL SCIENCES

Abstract

Coronavirus belongs to the family of Coronaviridae and is structurally enveloped with positive sense single strand. The virus undergoes replication by transcription of a minus strand template by RNA dependent RNA polymerase. The search is ongoing for the specific targeted treatment of corona virus infection. Among the available drugs to treat viral infections, there are few with promise to treat or reduce viral load. Never the less prevention is the best method to tackle the viral infection. The drugs used in the treatment of CoVid 19 according to the evidence available from the past with management of Severe Acute Respiratory Syndrome Corona Virus (SARS Covid 2) and Middle East Respiratory Syndrome Corona Virus (MERS Covid). The options available for treatment of Covid 19 are antiviral drugs and supportive interventions. The currently available drugs used in viral infections are explored for their additional benefit in treating CoVid 19 along with the immune boosters which include vitamins, essential minerals and biological response modifiers.

Keywords: Covid 19, potential drugs, Severe Acute Respiratory Syndrome, Middle Eastern Respiratory Syndrome, Immune boosters